OLMA - Olema Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
10.73 -0.33 (-3.03%)	---	---	---	0.59 (5.5%)	-0.25 (-2.4%)	-0.1 (-0.91%)	-0.1 (-0.91%)

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.51
Diluted EPS:: -0.51
Basic P/E:: -20.4012
Diluted P/E:: -20.4012
RSI(14) 1m:: 100.0
VWAP:: 10.4
RVol:: 1.0393

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	10.37 +0.13 (+1.27%)	Oct 15 15:45
1m	Price increase 1m	10.46 +0.14 (+1.36%)	Oct 15 11:29
1m	Price decrease 1m	10.54 -0.31 (-2.86%)	Oct 15 09:34
1m	Price decrease 1m	10.72 -0.13 (-1.2%)	Oct 15 09:33
1m	Price decrease 1m	10.72 -0.13 (-1.2%)	Oct 15 09:31